These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1281380)

  • 1. Studies on components of the plasma kallikrein system as a risk factor in diabetics undergoing cardiopulmonary bypass.
    Heller W; Gallimore MJ; Hoffmeister HE
    Agents Actions Suppl; 1992; 38 ( Pt 3)():311-6. PubMed ID: 1281380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the contact system in ascites from patients with gastrointestinal cancer.
    Buø L; Karlsrud TS; Johansen HT; Aasen AO
    Agents Actions Suppl; 1992; 38 ( Pt 2)():237-48. PubMed ID: 1281373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on components of the plasma kallikrein-kinin system in plasma samples from normal individuals and patients with septic shock.
    Aasen AO; Erichsen NS; Gallimore MJ; Amundsen E
    Adv Shock Res; 1980; 4():1-10. PubMed ID: 6172027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The changes and effects of the plasma levels of tumor necrosis factor after coronary artery bypass surgery with cardiopulmonary bypass.
    Abacilar F; Dogan OF; Duman U; Ucar I; Demircin M; Ersoy U; Dogan R; Boke E
    Heart Surg Forum; 2006; 9(4):E703-9. PubMed ID: 16844625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does avoidance of cardiopulmonary bypass decrease the incidence of stroke in diabetics undergoing coronary surgery?
    Abraham R; Karamanoukian HL; Jajkowski MR; von Fricken K; D'Ancona G; Bergsland J; Salerno TA
    Heart Surg Forum; 2001; 4(2):135-40. PubMed ID: 11544620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 8. [Activation of prekallikrein from human blood serum by different activators].
    Iarovaia GA; Dotsenko VL; Krizhevskaia IuV; Morozova NA; Orekhovich VN
    Biokhimiia; 1979 Jul; 44(7):1279-85. PubMed ID: 497275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of the activation and inhibition of the plasma kallikrein-kinin system.
    Kaplan AP; Reddigari S; Brunnée T; Nishikawa K; Kuna P; Silverberg M
    Agents Actions Suppl; 1992; 38 ( Pt 3)():317-28. PubMed ID: 1462866
    [No Abstract]   [Full Text] [Related]  

  • 10. FXII levels, FXIIa-like activities and kallikrein activities in normal subjects and patients undergoing cardiac surgery.
    Wendel HP; Jones DW; Gallimore MJ
    Immunopharmacology; 1999 Dec; 45(1-3):141-4. PubMed ID: 10615003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prekallikrein activity in patients with total hip arthroplasty.
    Hoffmann JJ; Kortmann JH
    Thromb Haemost; 1987 Dec; 58(4):1040-2. PubMed ID: 3445224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on Hageman factor, plasma prekallikrein, kallikrein "like" activity and kallikrein inhibition in plasma samples from normal subjects and clinical material.
    Egberg N; Gallimore MJ
    Adv Exp Med Biol; 1983; 156 (Pt B)():1109-17. PubMed ID: 6552857
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma kallikrein activation and inhibition during typhoid fever.
    Colman RW; Edelman R; Scott CF; Gilman RH
    J Clin Invest; 1978 Feb; 61(2):287-96. PubMed ID: 74379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical studies of plasma kallikrein.
    Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
    J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial.
    Kaya K; Oğuz M; Akar AR; Durdu S; Aslan A; Erturk S; Taşöz R; Ozyurda U
    Eur J Cardiothorac Surg; 2007 Feb; 31(2):290-7. PubMed ID: 17174559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallikrein-kinin system in diabetic patients.
    Uehara S; Isogawa S; Sakamoto W; Hirayama A
    Arzneimittelforschung; 1988 May; 38(5):721-3. PubMed ID: 3415716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation factors of contact phase of haemostasis are normal in well-controlled type-I diabetic patients despite presence of diabetic retinopathy.
    Watzke H; Schernthaner G; Schnack C; Schwarz HP; Prskavec F; Freyler H
    Diabetes Res; 1988 Apr; 7(4):197-200. PubMed ID: 3402169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose dependence of endotoxin-induced activation of the plasma contact system: an in vitro study.
    Roeise O; Bouma BN; Stadaas JO; Aasen AO
    Circ Shock; 1988 Dec; 26(4):419-30. PubMed ID: 2463883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The contact phase of blood coagulation in diabetes mellitus and in patients with vasculopathy.
    Christe M; Gattlen P; Fritschi J; Lämmle B; Berger W; Marbet GA; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):221-3. PubMed ID: 6085193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes is not a risk factor for hospital mortality following contemporary coronary artery bypass grafting.
    Filsoufi F; Rahmanian PB; Castillo JG; Mechanick JI; Sharma SK; Adams DH
    Interact Cardiovasc Thorac Surg; 2007 Dec; 6(6):753-8. PubMed ID: 17901106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.